Skip to main content

Table 1 Expression of serine/glycine metabolism-related proteins according to the subtype of thyroid cancer

From: Expression of serine/glycine metabolism-related proteins is different according to the thyroid cancer subtype

Parameters

Total n = 557 (%)

PTC n = 344 (%)

FC n = 112 (%)

MC n = 70 (%)

PDC n = 23 (%)

AC n = 8 (%)

P value

PHGDH in tumor

<0.001

 Negative

252 (45.2)

126 (36.6)

58 (51.8)

59 (84.3)

5 (21.7)

4 (50.0)

 

 Positive

305 (54.8)

218 (63.4)

54 (48.2)

11 (15.7)

18 (78.3)

4 (50.0)

 

PSAT1 in tumor

0.001

 Negative

477 (85.6)

280 (81.4)

103 (92.0)

69 (98.6)

18 (78.3)

7 (87.5)

 

 Positive

80 (14.4)

64 (18.6)

9 (8.0)

1 (1.4)

5 (21.7)

1 (12.5)

 

PSPH in tumor

0.008

 Negative

497 (89.2)

300 (87.2)

101 (90.2)

70 (100.0)

18 (78.3)

8 (100.0)

 

 Positive

60 (10.8)

44 (12.8)

11 (9.8)

0 (0.0)

5 (21.7)

0 (0.0)

 

SHMT1 in tumor

<0.001

 Negative

415 (74.5)

236 (68.6)

94 (83.9)

63 (90.0)

16 (69.6)

6 (75.0)

 

 Positive

142 (25.5)

108 (31.4)

18 (16.1)

7 (10.0)

7 (30.4)

2 (25.0)

 

SHMT1 in stroma

<0.001

 Negative

413 (74.1)

212 (61.6)

112 (100.0)

65 (92.9)

21 (91.3)

3 (37.5)

 

 Positive

144 (25.9)

132 (38.4)

0 (0.0)

5 (7.1)

2 (8.7)

5 (62.5)

 

GLDC in tumor

0.529

 Negative

470 (84.4)

285 (82.8)

96 (85.7)

60 (85.7)

21 (91.3)

8 (100.0)

 

 Positive

87 (15.6)

59 (17.2)

16 (14.3)

10 (14.3)

2 (8.7)

0 (0.0)

 
  1. PTC papillary thyroid carcinoma; FC follicular carcinoma; MC medullary carcinoma; PDC poorly differentiated carcinoma; AC anaplastic carcinoma; PHGDH phosphoglycerate dehydrogenase; PSAT phosphoserine aminotransferase; PSPH phosphoserine phosphatase; SHMT serine hydromethyl transferase; GLDC glycine decarboxylase
  2. Italic values represent p < 0.05